Abstract:This study reports the successful synthesis of core-shell microparticles utilizing coaxial electrospray techniques, with zeolitic imidazolate framework-8 (ZIF-8) encapsulating rhodamine B (RhB) in the core and a phase change material (PCM) shell composed of a eutectic mixture of lauric acid (LA) and stearic acid (SA). ZIF-8 is well-recognized for its pH-responsive degradation and biocompatibility, making it an ideal candidate for targeted drug delivery. The LA-SA PCM mixture, with a melting point near physiological temperature (39 °C), enables temperature-triggered drug release, enhancing therapeutic precision. The structural properties of the microparticles were extensively characterized through scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA). Drug release studies revealed a dual-stimuli response, where the release of RhB was significantly influenced by both temperature and pH. Under mildly acidic conditions (pH 4.0) at 40 °C, a rapid and complete release of RhB was observed within 120 h, while at 37 °C, the release rate was notably slower. Specifically, the release at 40 °C was 79% higher than at 37 °C, confirming the temperature sensitivity of the system. Moreover, at physiological pH (7.4), minimal drug release occurred, demonstrating the system's potential for minimizing premature drug release under neutral conditions. This dual-stimuli approach holds promise for improving therapeutic outcomes in cancer treatment by enabling precise control over drug release in response to both pH and localized hyperthermia, reducing off-target effects and improving patient compliance.

Remarkably Boosted Molecular Delivery Triggered by Combined Thermal and Flexoelectrical Field Dual Stimuli

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

A New Way to Promote Molecular Drug Release during Medical Treatment: A Polyelectrolyte Matrix on a Piezoelectric-Dielectric Energy Conversion Substrate.

Bifunctional Self‐Powered Drug Delivery System to Promote the Release and Transdermal Delivery of Polar Molecules

Electromagnetic Triggering with Microparticles for Application in Drug Delivery

Drug Delivery: Multi‐Stimuli‐Responsive Microcapsules for Adjustable Controlled‐Release (Adv. Funct. Mater. 22/2014)

A Self-Powered Delivery Substrate Boosts Active Enzyme Delivery In Response To Human Movements

A Miniaturized Device for Ultrafast On-demand Drug Release based on a Gigahertz Ultrasonic Resonator

Preparation and performance of a stimuli-responsive drug delivery system: novel light-triggered temperature-sensitive drug-loaded microcapsules

Self-Powered Intracellular Drug Delivery by a Biomechanical Energy-Driven Triboelectric Nanogenerator

Drug Release from Electric-Field-Responsive Nanoparticles

Stretch-Triggered Drug Delivery from Wearable Elastomer Films Containing Therapeutic Depots

Remotely Controlling Drug Release by Light-Responsive Cholesteric Liquid Crystal Microcapsules Triggered by Molecular Motors

Synthesis of High Drug Loading, Reactive Oxygen Species and Esterase Dual-Responsive Polymeric Micelles for Drug Delivery.

Electrically Controlled Rapid Release of Actives Encapsulated in Double-Emulsion Droplets

Flexible Drug Release Device Powered by Triboelectric Nanogenerator

Engineering pH and Temperature-Triggered Drug Release with Metal-Organic Frameworks and Fatty Acids

Smart soft photonic dressing toward fast drug release and visualized self-monitoring

An Ultra‐Swelling Microneedle Device for Facile And Efficient Drug Loading And Transdermal Delivery

Designing Dual-Responsive Drug Delivery Systems: The Role of Phase Change Materials and Metal–Organic Frameworks

Remote-Controlled Activation of the Release through Drug-Loaded Magnetic Electrospun Fibers